A 10-Year Plan
to Beat Inflammation
Over the next decade we will use our combined resources, infrastructure, and experience to accelerate our drug discovery efforts, investigating potential new therapies for rheumatoid arthritis, IBD, and many other inflammatory illnesses.
Our 10-Year Plan
Utilise our unique discovery engine
To find and deliver advanced new therapies
With a combined infrastructure that helps deliver to patients
While accelerating development of further advanced therapies
WE’RE FOCUSED ON ADVANCED
TREATMENTS FOR THE FUTURE.
Gilead and Galapagos are committed to advancing the treatment of inflammatory diseases and improving patient lives through our partnerships and collaborations with the scientific and medical community. We are studying multiple molecules for the treatment of IBD, with several clinical trials in both ulcerative colitis and Crohn’s disease.